Scoliosis Treatment Market Research Report - Forecast till 2027

Scoliosis Treatment Market Research Report: Information by Disease (Infantile Idiopathic Scoliosis and Adolescent Idiopathic Scoliosis), Product (Cervical Thoracic Lumbar Sacral Orthosis (CTLSO), Thoracolumbosacral Orthosis (TLSO) and Lumbosacral Orthosis (LSO)), Distribution Channel (Hospitals & Clinics, Retail Pharmacies and Online Pharmacies) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027

ID: MRFR/HC/6758-HCR | February 2021 | Region: Global | 95 pages

Scoliosis Treatment Market Overview


The Scoliosis Treatment Market will grow at a rate of 3.9 percent during Forecast period till 2025. The Scoliosis Treatment Market was valued at USD 2,580.2 million in 2018. The market is a growing one and will not stagnate over the forecast period. The Market  for Scoliosis Treatment is a major healthcare segment for the global healthcare market. As global healthcare gains in importance, Market will also see growth and progress over many aspects. The Market will continue to grow even till 2028 despite the different challenges it operates under.


In this Scoliosis Treatment Market Report, we will discuss the key drivers of the market, the trends and regional segmentation of the market, and the overall potential of the Market in the future.  Scoliosis is a disease that leads to spinal deformity and neural problems. Scoliosis is very common in children. Scoliosis is a health condition that leads to an abnormal curvature of the spine that alters the alignment of the vertebrae. Scoliosis has a huge impact on a person’s posture and balance because of the curving of the spinal axis. Scoliosis is less prevalent in adults. More teens suffer from the disease.


Scoliosis can arise from a birth defect, being congenital in nature. The disease can also be idiopathic. There are many causes of Scoliosis. These causes are weak ligaments, spondylolysis, bad posture, etc. When the patient suffers from Scoliosis, the person needs to undergo treatment. The treatment usually includes the use of braces. Braces keep the spine in its place and fix the body alignment. The braces have to be worn all the time. In severe cases, the Scoliosis management technique changes a lot. The patient with a severe case of Scoliosis needs to go through surgery. The doctor puts in implants to support the spine.


COVID 19 impact


The COVID 19 pandemic has impacted every other market in the world. The Market is no stranger to the impact of the COVID 19 pandemic. The Scoliosis Treatment industry saw an initial dip due to the impact of the pandemic. This was because most of the healthcare resources were channeled into COVID 19 treatment. This put other healthcare markets at a growth disadvantage. The immediate impact of the pandemic has been bad for the Market.


However, the long-term impact of the COVID 19 impact is increased attention to healthcare. There is a focus on complete wellbeing that was not present before. People are more aware of their healthcare needs and take multiple approaches to cure a disease. While the COVID 19 virus remains a primary concern, people’s attention towards overall wellbeing means that the Scoliosis Treatment Market has the advantage to work with. Due to the research and development of alternative approaches to Scoliosis disease management, the Market will grow.


Market Dynamics


Key Drivers


There are certain drivers of the Scoliosis Treatment Market that influence the market in a major way. Advancement in general in the Scoliosis Treatment industry applications and the increased incidence of Scoliosis in children and adults drive the growth of the market. The Market Growth will be supported by the advancement of new approaches to Scoliosis Treatment. The incidence of Scoliosis disease in the global population is also a key driver for the Market Size. According to the Clear Scoliosis Institute, Scoliosis is the most common type of spinal deformity among school children. In fact, every year nearly 17, 500 emergency visits happen from Scoliosis in children. With such prevalence of Scoliosis in small children, the Market grows through the forecast period.


Opportunities


The increased incidence of adult scoliosis due to lifestyle issues is also an opportunity for Scoliosis Treatment Market growth. Adults suffer from Scoliosis due to different reasons such as bad posture, lifestyle changes, and way too much stress to the spine. Adult scoliosis patients need long-term care. This means that an average adult scoliosis patient will require prolonged treatment and medical attention. Therefore, the Scoliosis Treatment Industry will benefit from a single Scoliosis patient for a long time.


Restraints


There are some restraints in the Scoliosis Treatment Market that hamper the growth of the market. The presence of rashes and skin irritation due to Scoliosis Treatment approaches like braces are one market restraint. The braces are long-term care options that will cause skin rash and irritation in many people. Therefore, the braces are not comfortable to wear. This creates a hindrance for the adoption of Scoliosis Treatment approaches by patients. This leads to a decrease in a brace and other implant sales. An inherent fear of spinal surgery among people, especially parents of young children, is also a market restraint for the Scoliosis Treatment Industry.


Challenges in the market


The challenges in the Scoliosis Treatment Market that need to be addressed are lack of awareness and lack of options.  A larger section of the patient population is not aware of the treatment options they have to treat Scoliosis. This leads to the disease becoming chronic for people. On the other hand, this means that they do not really seek treatment for the disease. This takes away the opportunity of expansion for the Scoliosis Treatment Industry Size. Another challenge is the limited options of Scoliosis Treatment. There is a lack of options which has led to the high cost of treatments in the sector. If there is ample research and development, the Scoliosis Treatment Industry will see more accessibility and Scoliosis Treatment Industry Growth. This will happen as an increased number of people goes for Scoliosis Treatment approaches.


Cumulative Growth Analysis


The Scoliosis Treatment Market has great growth prospects in the future, provided the market challenges are resolved. The market will see an organic growth spurt because of increased awareness of health conditions and treatments on a global scale. On the other hand, according to Scoliosis Treatment industry Analysis, the growth trends will not be uniform. 


Segment Overview


The Scoliosis Treatment Market divides into different segments based on different categories. The major categories of the Market Analysis by segment are disease, product, and distribution channels.


By disease- By disease, the Market divides into infantile idiopathic Scoliosis and adult idiopathic Scoliosis.


By Product- The Market divides into cervical, thoracic, CTLSO, TLSO, and LSO approaches.


By distribution channel- By distribution channels, the major channels for Scoliosis Treatment approaches are hospitals, clinics, and pharmacies.


The regional analysis of the Market is stated below.


Regional overview


The Scoliosis Treatment Market disperses over different regions of the world. The classification of the Scoliosis Treatment Industry according to regions includes North America, Europe, Asia Pacific, Middle East, and African region. The North American region will have the highest Scoliosis Treatment Industry share due to many reasons. The European market also shows promising signs of growth in the Scoliosis Treatment Industry Forecast period. The Asia Pacific region also has moderate growth projections in the future. However, the African region will have the lowest growth rate in the Scoliosis Treatment Industry share.


Competitive landscape 


There are many key players in the Market that dominate the competitive landscape for the market. 


The key players of the Scoliosis Treatment Market segment are as follows:



  • Boston Orthotics & Prosthetics

  • Chaneco

  • Charleston Bending Brace

  • Orthotech

  • Trulife

  • Össur

  • DJO


Recent Developments


The key players of the Scoliosis Treatment Industry are taking up further research and development to support the sector. The competitors are getting into collaborations and acquisitions. There are some who are merging too. For example, in 2020, Convexity Scientific acquired Wellinks Inc. In March 2019, another company Green Sun Medical conducted a pilot study into Dynamic Scoliosis Braces to introduce this new tech into the market.


Report Overview 


The Scoliosis Treatment Market Outlook or overview is as follows 



  • Market Overview

  • COVID 19 Analysis

  • Market Dynamics

  • Segment Overview

  • Regional Analysis

  • Competitive Landscape

  • Recent Developments


This report focuses on the Scoliosis Treatment Market trends and their growth projections. It highlights the key drivers, significant opportunities for growth, and presents market challenges of the Scoliosis Treatment Industry. Thirdly, it discusses the segmentation of the Scoliosis Treatment Industry over various benchmarks and segments. Additionally, the Scoliosis Treatment Industry Outlook sheds more light on the competitive landscape and recent developments of the market. It creates an overall reading of the Scoliosis Treatment Industry trends and future possibilities for the readers. 


 



Report Scope:
Report Attribute/Metric Details
  Market Size   2018 : USD 2,580.2 Million
  CAGR   3.9 (2019- 2025)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Disease, Product, Distribution Channel, Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   NuVasive, Spinal Technology, Inc., C H Martin Company, Aspen Medical Products, Lawall Prosthetics and Orthotics, SPINEFORM LLC, Össur, Orthotech, Chaneco, Boston Orthotics & Prosthetics, Charleston Bending Brace, Trulife, DJO, Wilmington Orthotics & Prosthetics, Inc., Horton's Orthotics & Prosthetics, UNYQ, Optec USA, Inc., and Zimmer Biomet Holdings Inc.
  Key Market Opportunities   The increased incidence of adult scoliosis due to lifestyle issues such as bad posture, lifestyle changes, and way too much stress to the spine.
  Key Market Drivers

  • Rising prevalence of scoliosis & musculoskeletal disorders
  • Growing demand for spine injuries


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    The scoliosis treatment market is projected to grow at a 3.9% CAGR between 2019-2025.

    The Americas are predicted to have the largest share in the scoliosis treatment market.

    Rising prevalence of scoliosis & musculoskeletal disorders and growing demand for spine injuries are boosting market growth.

    Lack of awareness and high cost may restrict market growth.

    Hospitals and clinics will dominate the scoliosis treatment market?

    Table of Contents

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Product Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Scoliosis Treatment Market, by Disease

    6.1 Introduction

    6.2 Infantile Idiopathic Scoliosis

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3 Adolescent Idiopathic Scoliosis

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 8. Global Scoliosis Treatment Market, by Product

    8.1 Introduction

    8.2 Cervical Thoracic Lumbar Sacral Orthosis (CTLSO)

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3 Thoracolumbosacral Orthosis (TLSO)

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.4 Lumbosacral Orthosis (LSO)

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 9. Global Scoliosis Treatment Market, by Distribution channel

    9.1 Introduction

    9.2 Hospitals & Clinics

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.3 Retail Pharmacies

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.4 Online Pharmacies

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 10. Market Estimates & Forecast, by Country, 2020-2027

    10.2.1 North America

    10.2.1.1 US

    10.2.1.2 Canada

    10.2.2 Latin America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 Italy

    10.3.1.4 Spain

    10.3.1.5 UK

    10.3.1.6 Rest of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia-Pacific

    10.4.1 Japan

    10.4.2 China

    10.4.3 India

    10.4.4 Australia

    10.4.5 South Korea

    10.4.6 Rest of Asia-Pacific

    10.5 Middle East & Africa

    10.5.1 Middle East

    10.5.2 Africa

    Chapter 11. Company Landscape

    11.1 Introduction

    11.2 Market Share Analysis

    11.3 Key Development & Strategies

    Chapter 12. Company Profiles

    12.1 Boston Orthotics & Prosthetics

    12.1.1 Company Overview

    12.1.2 Product Overview

    12.1.3 Financials Overview

    12.1.4 Key Developments

    12.1.5 SWOT Analysis

    12.2 Chaneco

    12.2.1 Company Overview

    12.2.2 Product Overview

    12.2.3 Financial Overview

    12.2.4 Key Developments

    12.2.5 SWOT Analysis

    12.3 Charleston Bending Brace

    12.3.1 Company Overview

    12.3.2 Product Overview

    12.3.3 Financial Overview

    12.3.4 Key Development

    12.3.5 SWOT Analysis

    12.4 Orthotech

    12.4.1 Company Overview

    12.4.2 Product Overview

    12.4.3 Financial Overview

    12.4.4 Key Development

    12.4.5 SWOT Analysis

    12.5 Trulife

    12.5.1 Company Overview

    12.5.2 Product Overview

    12.5.3 Financial overview

    12.5.4 Key Developments

    12.5.5 SWOT Analysis

    12.6 Össur

    12.6.1 Company Overview

    12.6.2 Product Overview

    12.6.3 Financial Overview

    12.6.4 Key Developments

    12.6.5 SWOT Analysis

    12.7 DJO

    12.7.1 Overview

    12.7.2 Product Overview

    12.7.3 Financial Overview

    12.7.4 Key Developments

    12.7.5 SWOT Analysis

    12.8 SPINEFORM LLC

    12.8.1 Overview

    12.8.2 Product Overview

    12.8.3 Financials

    12.8.4 Key Developments

    12.8.5 SWOT Analysis

    12.9 Wilmington Orthotics & Prosthetics, Inc.

    12.9.1 Overview

    12.9.2 Product Overview

    12.9.3 Financials

    12.9.4 Key Developments

    12.9.5 SWOT Analysis

    12.10 Lawall Prosthetics and Orthotics

    12.10.1 Overview

    12.10.2 Product Overview

    12.10.3 Financials

    12.10.4 Key Developments

    12.10.5 SWOT Analysis

    12.11 Horton's Orthotics & Prosthetics

    12.11.1 Overview

    12.11.2 Product Overview

    12.11.3 Financials

    12.11.4 Key Developments

    12.11.5 SWOT Analysis

    12.12 Aspen Medical Products

    12.12.1 Overview

    12.12.2 Product Overview

    12.12.3 Financials

    12.12.4 Key Developments

    12.12.5 SWOT Analysis

    12.13 UNYQ

    12.13.1 Overview

    12.13.2 Product Overview

    12.13.3 Financials

    12.13.4 Key Developments

    12.13.5 SWOT Analysis

    12.14 C H Martin Company

    12.14.1 Overview

    12.14.2 Product Overview

    12.14.3 Financials

    12.14.4 Key Developments

    12.14.5 SWOT Analysis

    12.15 Optec USA, Inc.

    12.15.1 Overview

    12.15.2 Product Overview

    12.15.3 Financials

    12.15.4 Key Developments

    12.15.5 SWOT Analysis

    12.16 Spinal Technology, Inc.

    12.16.1 Overview

    12.16.2 Product Overview

    12.16.3 Financials

    12.16.4 Key Developments

    12.16.5 SWOT Analysis

    12.17 Zimmer Biomet Holdings Inc.

    12.17.1 Overview

    12.17.2 Product Overview

    12.17.3 Financials

    12.17.4 Key Developments

    12.17.5 SWOT Analysis

    12.18 NuVasive

    12.18.1 Overview

    12.18.2 Product Overview

    12.18.3 Financials

    12.18.4 Key Developments

    12.18.5 SWOT Analysis

    Chapter 13 MRFR Conclusion

    13.1 Key Findings

    13.1.1 From CEO’s Viewpoint

    13.1.2 Unmet Needs of the Market

    13.2 Key Companies to Watch

    13.3 Predictions for the Cell Surface Markers Industry

    Chapter 14. Appendix

    LIST OF TABLES

    Table 1 Global Scoliosis Treatment Market Synopsis, 2020-2027

    Table 2 Global Scoliosis Treatment Market Estimates and Forecast, 2020-2027 (USD Million)

    Table 3 Global Scoliosis Treatment Market, by Region, 2020-2027 (USD Million)

    Table 4 Global Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)

    Table 5 Global Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)

    Table 6 Global Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)

    Table 7 North America: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)

    Table 8 North America: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)

    Table 9 North America: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)

    Table 10 Latin America: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)

    Table 11 Latin America: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)

    Table 12 Latin America: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)

    Table 13 Europe: Scoliosis Treatment Market, by Disease tye, 2020-2027 (USD Million)

    Table 14 Europe: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)

    Table 15 Europe: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)

    Table 16 Western Europe: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)

    Table 17 Western Europe: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)

    Table 18 Western Europe: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)

    Table 19 Eastern Europe: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)

    Table 20 Eastern Europe: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)

    Table 21 Eastern Europe: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)

    Table 22 Asia-Pacific: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)

    Table 23 Asia-Pacific: Scoliosis Treatment Market, by Product, 2020-2027 (USD Million)

    Table 24 Asia-Pacific: Scoliosis Treatment Market, by Distribution channel, 2020-2027 (USD Million)

    Table 25 Middle East & Africa: Scoliosis Treatment Market, by Disease, 2020-2027 (USD Million)

    Table 26 Middle East & Africa: Scoliosis Treatment Market, by Product, 2020-2027

    (USD Million)

    Table 27 Middle East & Africa: Scoliosis Treatment Market, by Distribution channel, 2020-2027

    (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Market Structure for Global Scoliosis Treatment Market

    Figure 3 Market Dynamics for Global Scoliosis Treatment Market

    Figure 4 Global Scoliosis Treatment, by Disease, 2020

    Figure 5 Global Scoliosis Treatment Market Share, by Product, 2020

    Figure 6 Global Scoliosis Treatment Market Share, by Distribution channel, 2020

    Figure 7 Global Scoliosis Treatment Market Share, by Region, 2020

    Figure 8 North America: Scoliosis Treatment Market Share, by Country, 2020

    Figure 9 Europe: Scoliosis Treatment Market Share, by Country, 2020

    Figure 10 Asia-Pacific: Scoliosis Treatment Market Share, by Country, 2020

    Figure 11 Middle East & Africa: Scoliosis Treatment Market Share, by Country, 2020

    Figure 12 Global Scoliosis Treatment Market: Company Share Analysis, 2020 (%)

    Figure 13 Boston Orthotics & Prosthetics, Inc.: Key Financials

    Figure 14 Boston Orthotics & Prosthetics, Inc.: Segmental Revenue

    Figure 15 Boston Orthotics & Prosthetics, Inc.: Geographical Revenue

    Figure 16 Chaneco Medical Solutions: Key Financials

    Figure 17 Chaneco Medical Solutions: Segmental Revenue

    Figure 18 Chaneco Medical Solutions: Geographical Revenue

    Figure 19 Charleston Bending Brace: Key Financials

    Figure 20 Charleston Bending Brace: Segmental Revenue

    Figure 21 Charleston Bending Brace: Geographical Revenue

    Figure 22 Orthotech: Key Financials

    Figure 23 Orthotech: Segmental Revenue

    Figure 24 Orthotech: Geographical Revenue

    Figure 25 Trulife: Key Financials

    Figure 26 Trulife: Segmental Revenue

    Figure 27 Trulife: Geographical Revenue

    Figure 28 Össur: Key Financials

    Figure 29 Össur: Segmental Revenue

    Figure 30 Össur: Geographical Revenue

    Figure 31 DJO: Key Financials

    Figure 32 DJO: Segmental Revenue

    Figure 33 DJO: Geographical Revenue

    Figure 34 SPINEFORM LLC: Financials

    Figure 35 SPINEFORM LLC: Segmental Revenue

    Figure 36 SPINEFORM LLC: Geographical Revenue

    Figure 37 Wilmington Orthotics & Prosthetics, Inc.: Key Financials

    Figure 38 Wilmington Orthotics & Prosthetics, Inc.: Segmental Revenue

    Figure 39 Wilmington Orthotics & Prosthetics, Inc.: Geographical Revenue

    Figure 40 Lawall Prosthetics and Orthotics: Key Financials

    Figure 41 Lawall Prosthetics and Orthotics: Segmental Revenue

    Figure 42 Lawall Prosthetics and Orthotics: Geographical Revenue

    Figure 43 Horton's Orthotics & Prosthetics: Key Financials

    Figure 44 Horton's Orthotics & Prosthetics: Segmental Revenue

    Figure 45 Horton's Orthotics & Prosthetics: Geographical Revenue

    Figure 46 Aspen Medical Products: Key Financials

    Figure 47 Aspen Medical Products: Segmental Revenue

    Figure 48 Aspen Medical Products: Geographical Revenue

    Figure 49 UNYQ: Key Financials

    Figure 50 UNYQ: Segmental Revenue

    Figure 51 UNYQ: Geographical Revenue

    Figure 52 C H Martin Company: Key Financials

    Figure 53 C H Martin Company: Segmental Revenue

    Figure 54 C H Martin Company: Geographical Revenue

    Figure 55 Optec USA, Inc.: Key Financials

    Figure 56 Optec USA, Inc.: Segmental Revenue

    Figure 57 Optec USA, Inc.: Geographical Revenue

    Figure 58 Spinal Technology, Inc.: Key Financials

    Figure 59 Spinal Technology, Inc.: Segmental Revenue

    Figure 60 Spinal Technology, Inc.: Geographical Revenue

    Figure 61 Zimmer Biomet Holdings Inc.: Key Financials

    Figure 62 Zimmer Biomet Holdings Inc.: Segmental Revenue

    Figure 63 Zimmer Biomet Holdings Inc.: Geographical Revenue

    Figure 64 NuVasive: Key Financials

    Figure 65 NuVasive: Segmental Revenue

    Figure 66 NuVasive: Geographical Revenue



    This table of content is tentative and subject to change as the research progresses.

    Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.